GCR Interactive: Pharmaceuticals – Collision of Biologics


With the biologics market a growing focus of development across the globe, what role does antitrust have to play in order to ensure healthy price competition between reference-priced biologics and competing biosimilars?

Hendrik Viaene speaks in this session which will focus on this role, and what lessons can and cannot be learned from generics, to help ensure low cost versions are available to all.

David Giardina, Sidley Austin

Sheng Li, NERA Economic Consulting
Elaine Johnston, Allen & Overy
Hendrik Viaene, McDermott, Will & Emery

For more information, and to register, please click here.

Dig Deeper

Virtual Event / Speaking Engagements / December 1-3, 2021

EIT Health Catapult Awards

Virtual Conference / Speaking Engagements / November 4, 2021

65th Annual IP Law Conference | Vaccines, IP and Global Equity

Miami, FL / Speaking Engagements / October 28, 2021

ABA’s 36th National Institute on White Collar Crime

Webinaire / McDermott Event / October 12, 2021

McDermott Paris | Café Concurrence I

Webinar / Dynamic Global Events / October 11-12, 2021

2nd REMS Virtual Summit

Get In Touch